MENU
DAWN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Day One Biopharmaceuticals (DAWN) Ownership - Who owns Day One Biopharmaceuticals?
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
754.07M
P/E Ratio
N/A
Total Cash
531.72M
Projected Growth
N/A
Total Debt
2.6M
Revenue
131.16M
Risk (Beta)
-1.64
Dividend Yield
N/A
Total Cash/Share
5.25
Total Debt/Equity
N/A
Revenue/Share
1.41 USD as % of share price
Fundamentals
DAWN
Capitalization
754M
P/E Ratio
N/A
Risk (Beta)
-1.64
Dividend Yield
N/A
Total Cash
532M
Total Cash/Share
5.25
Total Debt
2.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.41%
Revenue
131M
ROE
N/A
Book Value
503M
P/B Ratio
1.50
Cash Flow
N/A
Earnings
-1.02
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
7.66
Current Revenue Per Employee
161370.17
Dividends Per Share - Security
N/A
EBITDA
-215.24M
Float
N/A
Float - Current
N/A
Gross Income Margin
89.79
Revenue To Assets
-19.92
Shares Held By Institutions
1.66B
Shares Outstanding - Current
101M
Total Liabilities
80M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-41.279
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com